Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 111

1.

Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease.

Yates KP, Deppe R, Comerford M, Masuoka H, Cummings OW, Tonascia J, Chalasani N, Vuppalanchi R; NASH CRN.

PLoS One. 2017 Nov 2;12(11):e0185813. doi: 10.1371/journal.pone.0185813. eCollection 2017.

2.

Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease.

Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Abdelmalek M, Doo E, Tonascia JA, Kleiner DE, Sanyal AJ, Chalasani N; NASH Clinical Research Network.

Hepatology. 2017 Aug 31. doi: 10.1002/hep.29489. [Epub ahead of print]

PMID:
28859228
3.

Celecoxib-induced Liver Injury: Analysis of Published Case Reports and Cases Reported to the Food and Drug Administration.

Mukthinuthalapati PK, Fontana RJ, Vuppalanchi R, Chalasani N, Ghabril M.

J Clin Gastroenterol. 2017 Aug 8. doi: 10.1097/MCG.0000000000000888. [Epub ahead of print]

PMID:
28795997
4.

Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children.

Newton KP, Feldman HS, Chambers CD, Wilson L, Behling C, Clark JM, Molleston JP, Chalasani N, Sanyal AJ, Fishbein MH, Lavine JE, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN).

J Pediatr. 2017 Aug;187:141-146.e1. doi: 10.1016/j.jpeds.2017.03.007. Epub 2017 Mar 30.

PMID:
28366357
5.

Most Individuals With Advanced Cirrhosis Have Sleep Disturbances, Which Are Associated With Poor Quality of Life.

Ghabril M, Jackson M, Gotur R, Weber R, Orman E, Vuppalanchi R, Chalasani N.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1271-1278.e6. doi: 10.1016/j.cgh.2017.01.027. Epub 2017 Feb 3.

PMID:
28167158
6.

Differential Expression of miRNAs in Nontumor Liver Tissue of Patients With Hepatocellular Cancer Caused by Nonalcoholic Steatohepatitis Cirrhosis.

Liang T, Chalasani NP, Williams KE, Sarasani V, Janga SC, Vuppalanchi R.

Clin Gastroenterol Hepatol. 2017 Mar;15(3):465-467. doi: 10.1016/j.cgh.2016.10.017. Epub 2016 Oct 22. No abstract available.

PMID:
27780762
7.

Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.

Nelson JE, Handa P, Aouizerat B, Wilson L, Vemulakonda LA, Yeh MM, Kowdley KV; NASH Clinical Research Network.

Aliment Pharmacol Ther. 2016 Dec;44(11-12):1253-1264. doi: 10.1111/apt.13824. Epub 2016 Oct 11.

8.

Secondary Sclerosing Cholangitis From Spontaneous Choledochoduodenal Fistula.

Gromski MA, Fogel EL, Vuppalanchi R.

Clin Gastroenterol Hepatol. 2017 Mar;15(3):e71-e72. doi: 10.1016/j.cgh.2016.09.135. Epub 2016 Sep 23. No abstract available.

PMID:
27670380
9.

Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis.

Yang JD, Abdelmalek MF, Guy CD, Gill RM, Lavine JE, Yates K, Klair J, Terrault NA, Clark JM, Unalp-Arida A, Diehl AM, Suzuki A; Nonalcoholic Steatohepatitis Clinical Research Network.

Clin Gastroenterol Hepatol. 2017 Jan;15(1):127-131.e2. doi: 10.1016/j.cgh.2016.07.034. Epub 2016 Aug 12.

PMID:
27523635
10.

Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib.

Vuppalanchi R, Saxena R, Storniolo AMV, Chalasani N.

Hepatology. 2017 May;65(5):1762-1764. doi: 10.1002/hep.28720. Epub 2016 Aug 9. No abstract available.

PMID:
27397671
11.

Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study.

Zheng EX, Rossi S, Fontana RJ, Vuppalanchi R, Hoofnagle JH, Khan I, Navarro VJ.

Drug Saf. 2016 Aug;39(8):749-54. doi: 10.1007/s40264-016-0428-7.

12.

Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat.

Vuppalanchi R, Chalasani N.

Dig Dis Sci. 2016 Jul;61(7):1790-2. doi: 10.1007/s10620-016-4134-1. No abstract available.

PMID:
27010545
13.

Steatosis and liver stiffness measurements using transient elastography.

Eddowes P, Sasso M, Fournier C, Vuppalanchi R, Newsome P.

Hepatology. 2016 Aug;64(2):700. doi: 10.1002/hep.28515. Epub 2016 Apr 4. No abstract available.

PMID:
26928747
14.

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.

Eadon MT, Desta Z, Levy KD, Decker BS, Pierson RC, Pratt VM, Callaghan JT, Rosenman MB, Carpenter JS, Holmes AM, McDonald CA, Benson EA, Patil AS, Vuppalanchi R, Gufford BT, Dave N, Robarge JD, Hyder MA, Haas DM, Kreutz RP, Dexter PR, Skaar TC, Flockhart DA.

Clin Pharmacol Ther. 2016 Jul;100(1):63-6. doi: 10.1002/cpt.347. Epub 2016 Mar 31. Review.

15.

A not-so-sweet diagnosis: secondary biliary cirrhosis from a "lollipop" stone.

Gromski MA, Vuppalanchi R, Sherman S, Fogel EL.

Gastrointest Endosc. 2016 Jul;84(1):198-200. doi: 10.1016/j.gie.2015.12.008. Epub 2015 Dec 18. No abstract available.

16.

Febuxostat-induced acute liver injury.

Bohm M, Vuppalanchi R, Chalasani N; Drug-Induced Liver Injury Network (DILIN).

Hepatology. 2016 Mar;63(3):1047-9. doi: 10.1002/hep.28403. Epub 2016 Feb 3. No abstract available.

17.

Endoscopic Sedation in Roux-en-Y Gastric Bypass.

Vuppalanchi R.

Clin Gastroenterol Hepatol. 2016 Aug;14(8):1221. doi: 10.1016/j.cgh.2015.08.029. Epub 2015 Sep 16. No abstract available.

PMID:
26325400
18.

Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury.

Usachov V, Urban TJ, Fontana RJ, Gross A, Iyer S, Omary MB, Strnad P; Drug-Induced Liver Injury Network.

BMC Med. 2015 Aug 19;13:196. doi: 10.1186/s12916-015-0418-0.

19.

Individuals with Primary Sclerosing Cholangitis Have Elevated Levels of Biomarkers for Apoptosis but Not Necrosis.

Masuoka HC, Vuppalanchi R, Deppe R, Bybee P, Comerford M, Liangpunsakul S, Ghabril M, Chalasani N.

Dig Dis Sci. 2015 Dec;60(12):3642-6. doi: 10.1007/s10620-015-3805-7. Epub 2015 Jul 21.

20.

Drug-Induced Liver Injury.

Fisher K, Vuppalanchi R, Saxena R.

Arch Pathol Lab Med. 2015 Jul;139(7):876-87. doi: 10.5858/arpa.2014-0214-RA. Review.

PMID:
26125428

Supplemental Content

Loading ...
Support Center